PN
PEARL Neuroscience
PEARL Neuroscience develops first-in-class therapeutics targeting neuroinflammation to treat neurological disorders and aging. Their noninvasive nasal spray therapeutics aim to curb degeneration, promote functional regeneration, and delay aging across multiple indications. The company focuses on early-stage therapeutic R&D for conditions including Alzheimer's disease and Parkinson’s disease.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- PEARL Neuroscience develops first-in-class therapeutics targeting neuroinflammation to treat neurological disorders and aging. Their noninvasive nasal spray therapeutics aim to curb degeneration, promote functional regeneration, and delay aging across multiple indications. The company focuses on early-stage therapeutic R&D for conditions including Alzheimer's disease and Parkinson’s disease.